Cargando…
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610707/ https://www.ncbi.nlm.nih.gov/pubmed/26508844 http://dx.doi.org/10.2147/CIA.S97145 |
Ejemplares similares
-
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives
por: Gareri, Pietro, et al.
Publicado: (2015) -
Neuroprotective Properties of Citicoline: Facts, Doubts and Unresolved Issues
por: Grieb, Pawel
Publicado: (2014) -
Citicoline (Cognizin) in the treatment of cognitive impairment
por: Fioravanti, Mario, et al.
Publicado: (2006) -
Corrigendum: Advantages and pitfalls of clinical application of sugammadex
por: Lee, Hyung Young, et al.
Publicado: (2022) -
Corrigendum: Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
Publicado: (2021)